Life Saving Drugs Program – MPS I – Review summary and expert panel recommendations

This MPS I review considered laronidase. The Expert Panel considered this review at its October 2020 meeting. This document provides a summary of the review findings and recommendations.

Downloads

Life Saving Drugs Program – MPS I – Medicines review summary

We aim to provide documents in an accessible format. If you're having problems using a document with your accessibility tools, please contact us for help.

Publication date:
Publication type:
Procedure
Audience:
General public
Language:
English

Help us improve health.gov.au

If you would like a response please use the enquiries form instead.